Category
Pharmaceuticals & Healthcare Products
186 posts · page 1 of 19
Pharmaceuticals & Healthcare Products
India’s new CDSCO guidelines for expert panels in drug and device approvals and their impact on innovation
India's CDSCO guidelines aim to streamline drug approvals, boosting innovation.
Pharmaceuticals & Healthcare Products
India crossing 30 billion dollars in pharma exports for FY25 and what it means for global competitiveness
India's pharma exports soar, boosting global market presence.
Pharmaceuticals & Healthcare Products
Market behaviour in April 2025 and how price hikes and chronic therapies drove IPM growth
April 2025 saw dramatic price hikes fueling IPM growth.
Pharmaceuticals & Healthcare Products
How the streamlining of medical device clearance rules is changing regulatory timelines in Indian pharma
New rules are speeding up medical device approvals in India.
Pharmaceuticals & Healthcare Products
Lessons from the price erosion of empagliflozin post patent expiry in India
Empagliflozin's price drop reveals crucial market dynamics.
Pharmaceuticals & Healthcare Products
The rise of anti-obesity drugs like GLP-1 therapies in shaping India’s emerging markets
GLP-1 therapies are transforming India's obesity treatment landscape.
Pharmaceuticals & Healthcare Products
The pharma export portal shift and its implications for Indian exporters
India's pharma export portal shift reshapes global trade strategies.
Pharmaceuticals & Healthcare Products
Reduced regulatory violations in Indian pharma as USFDA observation rates decline
Indian pharma sees fewer USFDA violations, boosting confidence.
Pharmaceuticals & Healthcare Products
Growth drivers behind India’s pharma market growing 8.4% in FY25, especially in chronic therapies
India's pharma market thrives, driven by chronic therapy demand.
Pharmaceuticals & Healthcare Products
How regulatory clarity in biologics approval can open new growth frontiers in Indian pharma
Regulatory clarity can boost India's biologics sector significantly.
Page 1 / 19
Next →